SCHEMBL5812995

SCHEMBL5812995

CC1CCN(c2nc(-c3ccccc3F)c(-c3ccnc(NC4CC4)n3)s2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.39
RIPK2 O43353 1/20 0.39
BRAF P15056 1/20 0.38
CDK4 P11802 4/20 0.38
GSK3B P49841 2/20 0.38
CDK2 P24941 2/20 0.38
RET P07949 1/20 0.37
HRH4 Q9H3N8 3/20 0.37
IKBKB O14920 1/20 0.37
MAPK8 P45983 2/20 0.37
MAPK9 P45984 2/20 0.37
MAPK10 P53779 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5813579 0.96 HRH4 (0.42) KCNH2RIPK2CDK4GSK3BCDK2
SCHEMBL5818639 0.95 CDK1 (0.42) KCNH2CDK4GSK3BCDK2RET
SCHEMBL5814947 0.91 HRH4 (0.45) KCNH2RIPK2BRAFCDK4CDK2
SCHEMBL5813694 0.91 KCNH2 (0.45) KCNH2RIPK2BRAFCDK4GSK3B
SCHEMBL5818808 0.89 KCNH2 (0.50) KCNH2CDK4GSK3BCDK2IKBKB
SCHEMBL5812777 0.88 KCNH2 (0.45) KCNH2CDK4GSK3BCDK2RET
SCHEMBL5815424 0.88 KCNH2 (0.45) KCNH2CDK4GSK3BCDK2RET
SCHEMBL5817256 0.87 HRH4 (0.51) KCNH2CDK4CDK2RETHRH4
SCHEMBL5818778 0.86 HRH4 (0.50) KCNH2CDK4GSK3BCDK2RET
SCHEMBL5813653 0.85 KCNH2 (0.51) KCNH2CDK4GSK3BCDK2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed